News

This content was published in the EU4MD update released on 4.07.2022. This update also presents a section on partnerships, announcements, studies, upcoming events, and a research corner. Focus on prevention systems in...

A Ukrainian version of the European Prevention Curriculum (EUPC) handbook, adapted for the local context, has been launched today in Kyiv at an event organised by the non-governmental organisation, Geopolitical Alliance of...

The online space has become increasingly relevant in identifying trends in illicit drug supply and demand. With increased internet activity globally, drug-related social interactions and purchases have also partially moved online. Against...

Analysing potential futures to support decision-making today is increasingly used in a world characterised by rapid, volatile and complex change. More and more organisations, including EU bodies ( 1 ), are integrating...

The EU drugs agency (EMCDDA) and the University Institute of Lisbon (ISCTE-IUL) will be continuing their fruitful 10-year cooperation, thanks to a new Memorandum of Understanding (MoU) signed between the two bodies...

Good morning, First of all, I would like to express our warm thanks to Commissioner Ylva Johansson for her permanent support and also to Dr Franz Pietsch, the Chair of the EMCDDA...

Vice-Prime Minister and Minister of Health of Luxembourg Paulette Lenert visits the EMCDDA today during an official visit to Portugal. The Minister will meet EMCDDA Director Alexis Goosdeel and Chair of the...

2021 was a year of transformation for the EMCDDA as the agency reached new milestones in its journey towards a customer-centric, data-driven and digitally-enabled organisation. These developments are described in the latest...

This year, the EU Early Warning System ( EWS ) on new psychoactive substances ( NPS ) celebrates its 25th anniversary. Operated by the EMCDDA , in close cooperation with Europol and...

The rapid bounce back of drug supply and use following COVID-19 disruption is among the issues highlighted today by the EU drugs agency (EMCDDA) as it launches its European Drug Report 2022...

It is a great honour for me, as Chair of the EMCDDA Management Board, to introduce the European Drug Report 2022 . This annual report delivers the latest overview of the drug...

Good morning everyone, We are presenting this year's European Drug Report at a time when we are celebrating 25 years of the EU Early Warning System. 25 years of alerting Europe to...

The European Drug Report 2022: Trends and Developments arrives at a time when recent major global events have impacted profoundly on all areas of our life and, therefore, also have implications for...

This year, the EU Early Warning System ( EWS ) on new psychoactive substances ( NPS ) celebrates its 25th anniversary. Operated by the EMCDDA, in close cooperation with Europol and partners...

Today, the EMCDDA is holding the second annual meeting of its Legal and policy correspondents’ network for non-EU partners, following an inaugural meeting in October 2021. The EMCDDA’s regular EU Legal and...

Today, the European School Survey Project on Alcohol and Other Drugs ( ESPAD ) is launching a new data explorer tool , allowing access to over 20 years of ESPAD data on...

What do the latest data tell us about trends in drug use and the market? What hazardous new drugs are emerging? What substances are posing the greatest health threats? Find out more...

Staff members of the Georgian national drug observatory (NDO) are at the EMCDDA this week for a workshop on drug monitoring and reporting. The event is taking place under the technical cooperation...

Representatives of candidate, potential candidate and neighbouring countries of the EU are joining members of the EMCDDA’s Reitox network this week (10–13 May) for the agency’s tenth Reitox week. The purpose of...

Europe’s role in international drug production and trade is changing, according to new analyses released today by the EU drugs agency (EMCDDA) and Europol ( 1 ). In an in-depth look at...